Physician profile
John M Paddack
NPI 1780819607
$2,786.38
in general payments reported to CMS, 2019-2025
22 companies · $231 in 2025
The $231 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $41.45 · 2020: $170 · 2021: $927 · 2022: $119 · 2023: $243 · 2024: $1,054 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $802 · Travel and Lodging: $727.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $801.55 |
| Travel and Lodging | $727.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,048.66 | 2024-2025 | Aquabeam System |
| Teleflex LLC | $706.43 | 2021-2025 | Barrigel |
| Neotract INC. | $119.82 | 2020 | |
| Axonics, INC. | $104.78 | 2022-2023 | Bulkamid, Axonics |
| Myriad Genetic Laboratories, INC. | $97.25 | 2023 | Prolaris |
| Astellas Pharma US INC | $93.80 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $85.00 | 2023-2025 | Gemtesa, Orgovyx |
| Laborie Medical Technologies Corp. | $83.42 | 2021-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Rochester Medical Corporation | $71.06 | 2020-2022 | |
| Boston Scientific Corporation | $70.67 | 2020-2022 | |
| Myovant Sciences INC. | $66.11 | 2021 | |
| Olympus America INC. | $48.01 | 2023-2025 | Uretero-Reno Videoscope, Itind System |
| Abbvie INC. | $35.16 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.59 | 2025 | |
| Medtronic, INC. | $19.76 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $18.62 | 2024 | Provenge |
| Janssen Biotech, INC. | $17.60 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $16.43 | 2023 | Bard Urinary Drainage Bag |
| Ferring Pharmaceuticals INC. | $15.90 | 2024 | Adstiladrin |
| Pfizer INC. | $15.55 | 2025 | |
| Endo Pharmaceuticals INC. | $15.31 | 2022 | |
| Coloplast Corp | $12.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Paddack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.